Setnik B - Search Results

1

Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial.

Schoedel KA, Szeto I, Setnik B, Sellers EM, Levy-Cooperman N, Mills C, Etges T, Sommerville K. Schoedel KA, et al. Among authors: setnik b. Epilepsy Behav. 2018 Nov;88:162-171. doi: 10.1016/j.yebeh.2018.07.027. Epub 2018 Oct 2. Epilepsy Behav. 2018. PMID: 30286443 Free article. Clinical Trial.

2

Identification of Optimal Measures of Human Abuse Potential: A Post Hoc Assessment of 19 Studies.

Shram MJ, Levy-Cooperman N, Ratcliffe S, Mills C, Bartlett C, Chen N, Setnik B, Sellers EM, Schoedel KA. Shram MJ, et al. Among authors: setnik b. J Clin Psychopharmacol. 2020 Nov/Dec;40(6):568-578. doi: 10.1097/JCP.0000000000001302. J Clin Psychopharmacol. 2020. PMID: 33086237

3

Assessment of pharmacodynamic effects following oral administration of crushed morphine sulfate and naltrexone hydrochloride extended-release capsules compared with crushed morphine sulfate controlled-release tablets and placebo in nondependent recreational opioid users.

Setnik B, Sommerville K, Goli V, Han L, Webster L. Setnik B, et al. Pain Med. 2013 Aug;14(8):1173-86. doi: 10.1111/pme.12148. Epub 2013 Jun 7. Pain Med. 2013. PMID: 23745947 Clinical Trial.

4

Assessing the subjective and physiological effects of intranasally administered crushed extended-release morphine formulations with and without a sequestered naltrexone core in recreational opioid users.

Setnik B, Goli V, Levy-Cooperman N, Mills C, Shram M, Smith I. Setnik B, et al. Pain Res Manag. 2013 Jul-Aug;18(4):e55-62. doi: 10.1155/2013/952082. Pain Res Manag. 2013. PMID: 23936895 Free PMC article. Clinical Trial.

5

Intranasal administration of crushed ALO-02 (extended-release oxycodone with sequestered naltrexone): A randomized, controlled abuse-potential study in nondependent recreational opioid users.

Setnik B, Bramson C, Bass A, Levy-Cooperman N, Malhotra B, Matschke K, Sommerville KW, Wolfram G, Geoffroy P. Setnik B, et al. J Clin Pharmacol. 2015 Dec;55(12):1351-61. doi: 10.1002/jcph.552. Epub 2015 Jul 2. J Clin Pharmacol. 2015. PMID: 26011742 Clinical Trial.

6

Abuse Potential Study of ALO-02 (Extended-Release Oxycodone Surrounding Sequestered Naltrexone) Compared with Immediate-Release Oxycodone Administered Orally to Nondependent Recreational Opioid Users.

Setnik B, Bass A, Bramson C, Levy-Cooperman N, Malhotra B, Matschke K, Geoffroy P, Sommerville KW, Wolfram G. Setnik B, et al. Pain Med. 2017 Jun 1;18(6):1077-1088. doi: 10.1093/pm/pnw178. Pain Med. 2017. PMID: 27550954 Free PMC article. Clinical Trial.

7

Prescription opioid abuse and misuse: gap between primary-care investigator assessment and actual extent of these behaviors among patients with chronic pain.

Setnik B, Roland CL, Pixton GC, Sommerville KW. Setnik B, et al. Postgrad Med. 2017 Jan;129(1):5-11. doi: 10.1080/00325481.2017.1245585. Epub 2016 Oct 26. Postgrad Med. 2017. PMID: 27782769 Clinical Trial.

8

Intranasal abuse potential of an abuse-deterrent oxycodone formulation compared to oxycodone immediate release and placebo in nondependent, recreational opioid users.

Setnik B, Schoedel K, Bartlett C, Dick C, Hakim N, Geoffroy P. Setnik B, et al. J Opioid Manag. 2017 Nov/Dec;13(6):449-464. doi: 10.5055/jom.2017.0421. J Opioid Manag. 2017. PMID: 29308591 Clinical Trial.

9

Evaluating the abuse potential of opioids and abuse-deterrent -opioid formulations: A review of clinical study methodology.

Setnik B, Schoedel KA, Levy-Cooperman N, Shram M, Pixton GC, Roland CL. Setnik B, et al. J Opioid Manag. 2017 Nov/Dec;13(6):485-523. doi: 10.5055/jom.2017.0412. J Opioid Manag. 2017. PMID: 29308594 Review.

10

Subjective effects and safety of whole and tampered morphine sulfate and naltrexone hydrochloride (ALO-01) extended-release capsules versus morphine solution and placebo in experienced non-dependent opioid users: a randomized, double-blind, placebo-controlled, crossover study.

Stauffer J, Setnik B, Sokolowska M, Romach M, Johnson F, Sellers E. Stauffer J, et al. Among authors: setnik b. Clin Drug Investig. 2009;29(12):777-90. doi: 10.2165/11530800-000000000-00000. Clin Drug Investig. 2009. PMID: 19888784 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters